Basic Information
Cullgen is a drug discovery company that utilizes small molecule-induced protein degradation technology mediated by ubiquitin, focusing on novel treatments for cancer, inflammation, and autoimmune diseases. The company was founded in 2018 by Dr. Ying Luo, a Chinese scientist.
Cullgen, INC.
SanDiego,California,United States of America
15~50 people
January 01, 2018
inquiries@cullgen.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios